BRPI9907084B8 - processo para a preparação de uma composição compreendendo cefalosporina amorfa cristalograficamente estável - Google Patents
processo para a preparação de uma composição compreendendo cefalosporina amorfa cristalograficamente estávelInfo
- Publication number
- BRPI9907084B8 BRPI9907084B8 BRPI9907084A BR9907084A BRPI9907084B8 BR PI9907084 B8 BRPI9907084 B8 BR PI9907084B8 BR PI9907084 A BRPI9907084 A BR PI9907084A BR 9907084 A BR9907084 A BR 9907084A BR PI9907084 B8 BRPI9907084 B8 BR PI9907084B8
- Authority
- BR
- Brazil
- Prior art keywords
- preparing
- product
- composition
- high molecular
- water
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title abstract 4
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 229930186147 Cephalosporin Natural products 0.000 title 1
- 229940124587 cephalosporin Drugs 0.000 title 1
- 150000001780 cephalosporins Chemical class 0.000 title 1
- 239000000047 product Substances 0.000 abstract 3
- 239000000654 additive Substances 0.000 abstract 2
- 230000000996 additive effect Effects 0.000 abstract 2
- 229960002142 cefditoren pivoxil Drugs 0.000 abstract 2
- AFZFFLVORLEPPO-UVYJNCLZSA-N cefditoren pivoxil Chemical compound S([C@@H]1[C@@H](C(N1C=1C(=O)OCOC(=O)C(C)(C)C)=O)NC(=O)\C(=N/OC)C=2N=C(N)SC=2)CC=1\C=C/C=1SC=NC=1C AFZFFLVORLEPPO-UVYJNCLZSA-N 0.000 abstract 2
- 239000002245 particle Substances 0.000 abstract 2
- 239000000843 powder Substances 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 239000002253 acid Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 238000001035 drying Methods 0.000 abstract 1
- 239000008240 homogeneous mixture Substances 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 230000003472 neutralizing effect Effects 0.000 abstract 1
- 239000002244 precipitate Substances 0.000 abstract 1
- 238000002360 preparation method Methods 0.000 abstract 1
- 239000000243 solution Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
- A61K31/542—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with heterocyclic ring systems
- A61K31/545—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine
- A61K31/546—Compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins, cefaclor, or cephalexine containing further heterocyclic rings, e.g. cephalothin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D501/00—Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
- C07D501/14—Compounds having a nitrogen atom directly attached in position 7
- C07D501/16—Compounds having a nitrogen atom directly attached in position 7 with a double bond between positions 2 and 3
- C07D501/20—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids
- C07D501/24—7-Acylaminocephalosporanic or substituted 7-acylaminocephalosporanic acids in which the acyl radicals are derived from carboxylic acids with hydrocarbon radicals, substituted by hetero atoms or hetero rings, attached in position 3
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Cephalosporin Compounds (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP192098 | 1998-01-07 | ||
| PCT/JP1999/000020 WO1999034832A1 (en) | 1998-01-07 | 1999-01-07 | Crystallographically stable amorphous cephalosporin compositions and process for producing the same |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| BR9907084A BR9907084A (pt) | 2000-10-17 |
| BRPI9907084B1 BRPI9907084B1 (pt) | 2017-04-25 |
| BRPI9907084B8 true BRPI9907084B8 (pt) | 2021-05-25 |
Family
ID=11515039
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI9907084A BRPI9907084B8 (pt) | 1998-01-07 | 1999-01-07 | processo para a preparação de uma composição compreendendo cefalosporina amorfa cristalograficamente estável |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US6342493B1 (cs) |
| EP (1) | EP1051978B1 (cs) |
| JP (1) | JP3413406B2 (cs) |
| KR (1) | KR100435315B1 (cs) |
| CN (1) | CN1151845C (cs) |
| AU (1) | AU736555B2 (cs) |
| BR (1) | BRPI9907084B8 (cs) |
| CA (1) | CA2316841C (cs) |
| CZ (1) | CZ302082B6 (cs) |
| EA (1) | EA002881B1 (cs) |
| ES (1) | ES2393972T3 (cs) |
| HU (1) | HU230295B1 (cs) |
| ID (1) | ID25469A (cs) |
| IL (2) | IL137004A0 (cs) |
| NZ (1) | NZ505871A (cs) |
| PL (1) | PL194097B1 (cs) |
| PT (1) | PT1051978E (cs) |
| SK (1) | SK286631B6 (cs) |
| TR (1) | TR200001903T2 (cs) |
| TW (1) | TW587946B (cs) |
| UA (1) | UA70311C2 (cs) |
| WO (1) | WO1999034832A1 (cs) |
Families Citing this family (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EA002881B1 (ru) * | 1998-01-07 | 2002-10-31 | Мейдзи Сейка Кайся Лтд. | Кристаллографически стабильные аморфные цефалоспориновые композиции и способ их получения |
| ATE285821T1 (de) | 1999-10-08 | 2005-01-15 | Affinium Pharm Inc | Fab i inhibitoren |
| DK1560584T3 (da) | 2001-04-06 | 2009-05-18 | Affinium Pharm Inc | Fab I inhibitorer |
| JPWO2002087588A1 (ja) * | 2001-04-26 | 2004-08-12 | 明治製菓株式会社 | 非晶質セフジトレンピボキシル組成物およびその製造方法 |
| PT1555024E (pt) * | 2002-10-02 | 2010-11-18 | Meiji Seika Kaisha | Composição medicinal antibacteriana com absorção oral melhorada |
| WO2004052890A1 (en) | 2002-12-06 | 2004-06-24 | Affinium Pharmaceuticals, Inc. | Heterocyclic compounds, methods of making them and their use in therapy |
| DE602004016831D1 (de) * | 2003-03-17 | 2008-11-13 | Affinium Pharm Inc | Pharmazeutische zusammensetzungen inhibitoren von fab i und weitere antibiotika enthaltend |
| WO2004113424A1 (ja) * | 2003-06-20 | 2004-12-29 | Meiji Seika Kaisha, Ltd. | 難水溶性物質と水溶性高分子との共沈物の製造方法 |
| KR101178657B1 (ko) | 2003-10-08 | 2012-08-30 | 메이지 세이카 파루마 가부시키가이샤 | 세프디토렌 피복실을 함유하는 비결정질 항균 조성물 |
| WO2005044824A2 (en) * | 2003-11-07 | 2005-05-19 | Ranbaxy Laboratories Limited | Processes for the preparation of highly pure 3-(2-substituted vinyl) cephalosporin |
| JP2005162696A (ja) * | 2003-12-04 | 2005-06-23 | Nichiko Pharmaceutical Co Ltd | 溶出性に優れたセフジトレンピボキシル製剤 |
| WO2005082330A2 (en) * | 2004-02-19 | 2005-09-09 | Ranbaxy Laboratories Limited | Co-precipitated amorphous cefditoren pivoxil and dosage forms comprising the same |
| EP2848614A3 (en) | 2004-06-04 | 2015-07-29 | Debiopharm International SA | Acrylamide derivatives as antibiotic agents |
| US20080069879A1 (en) * | 2006-05-02 | 2008-03-20 | Ravishekhar Bhiwgade | Stable solid dosage form containing amorphous cefditoren pivoxil and process for preparation thereof |
| JP5468899B2 (ja) | 2006-07-20 | 2014-04-09 | アフィニウム ファーマシューティカルズ， インク． | Ｆａｂｉインヒビターとしてのアクリルアミド誘導体 |
| WO2008057058A1 (en) * | 2006-11-10 | 2008-05-15 | Nobel Ilac Sanayii Ve Ticaret As | Oral pharmaceutical compositions |
| EP3255045A1 (en) | 2007-02-16 | 2017-12-13 | Debiopharm International SA | Salts, prodrugs and polymorphs of fab i inhibitors |
| CN101560216B (zh) * | 2009-05-27 | 2011-06-15 | 上海交通大学 | 头孢妥仑酯的制备方法 |
| US20130143857A1 (en) * | 2010-07-23 | 2013-06-06 | Lupin Limited | Pharmaceutical compositions of cefditoren pivoxil |
| ES2554630T3 (es) | 2010-09-30 | 2015-12-22 | Toyama Chemical Co., Ltd. | Sal sódica de 6-fluoro-3-hidroxi-2-pirazinocarboxamida |
| HUE026794T2 (en) | 2010-09-30 | 2016-07-28 | Toyama Chemical Co Ltd | Meglumine salt of 6-fluoro-3-hydroxy-2-pyrazine carboxamide |
| BR112014031635B1 (pt) | 2012-06-19 | 2022-01-11 | Debiopharm International Sa | Derivados de pró-fármaco de (e)-n-metil-n-( (3-metilbenzofuran-2-il) metil)-3-(7-oxo-5,6,7,8- tetraidro- 1, 8- naftirindin-3-il) acrilamida |
| IN2013MU02828A (cs) * | 2013-08-29 | 2015-07-03 | Cadila Healthcare Ltd | |
| EP3244879A1 (en) | 2015-01-16 | 2017-11-22 | Ögün, Yusuf Toktamis | Cefditoren pivoxil compositions with improved stability and production methods thereof |
| BR112018016721A2 (pt) | 2016-02-26 | 2018-12-26 | Debiopharm Int Sa | uso de di-hidrogeno fosfato de {6-[(e)-3-{metil[(3-metil-1-benfofuran-2-iol)metil]amino)-3-xopro-1-en-1-il]-2-oxo-3,4-di-hidro-1,8-naftiridin-1(2h)-il}metila e composição farmacêutica para tratamento de infecções bacterianas associadas ao pé diabético |
| CN109053768A (zh) * | 2018-08-07 | 2018-12-21 | 中国医药集团总公司四川抗菌素工业研究所 | 一种无定型头孢妥仑酯的制备方法 |
| BR112021015825B1 (pt) | 2019-02-14 | 2024-03-12 | Debiopharm International S.A. | Formulação de afabicina e método para obtenção da mesma |
| US12414958B2 (en) | 2019-06-14 | 2025-09-16 | Debiopharm International S.A. | Medicament and use thereof for treating bacterial infections involving biofilm |
| CN110251467A (zh) * | 2019-06-26 | 2019-09-20 | 北京济美堂医药研究有限公司 | 一种无定形态头孢妥仑匹酯组合物的制备方法 |
| CN112190539B (zh) * | 2020-11-10 | 2021-11-02 | 深圳立健药业有限公司 | 一种头孢妥仑匹酯组合物及其应用 |
| CN120732800A (zh) * | 2025-08-19 | 2025-10-03 | 湖南恒昌医药集团股份有限公司 | 头孢托仑匹酯缓释片及其制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0678234B2 (ja) * | 1988-04-19 | 1994-10-05 | 明治製菓株式会社 | 経口投与用抗菌組成物 |
| JPH05306227A (ja) * | 1992-04-27 | 1993-11-19 | Lion Corp | 徐放性口腔内疾患治療剤 |
| JP2576927B2 (ja) * | 1992-05-15 | 1997-01-29 | ファイザー製薬株式会社 | 細粒核 |
| JPH06316517A (ja) * | 1993-02-22 | 1994-11-15 | Grelan Pharmaceut Co Ltd | 放出制御製剤 |
| JPH0717866A (ja) * | 1993-06-16 | 1995-01-20 | Meiji Seika Kaisha Ltd | 医薬組成物 |
| AU4314196A (en) | 1994-12-21 | 1996-07-10 | Yamanouchi Pharmaceutical Co., Ltd. | Solid composition with improved solubility and absorbability |
| AR004014A1 (es) * | 1995-10-13 | 1998-09-30 | Meiji Seika Kaisha | Una composicion antibacteriana de cefditoren pivoxilo para administracion oral y metodo para obtener dicha composicion |
| DK0904060T3 (da) | 1996-05-20 | 2004-04-13 | Janssen Pharmaceutica Nv | Antifungale præparater med forbedret biotilgængelighed |
| ES2198593T3 (es) * | 1996-09-20 | 2004-02-01 | Meiji Seika Kaisha, Ltd. | Una sustancia cristalina de cefditoren pivoxil y la produccion de la misma. |
| EA002881B1 (ru) * | 1998-01-07 | 2002-10-31 | Мейдзи Сейка Кайся Лтд. | Кристаллографически стабильные аморфные цефалоспориновые композиции и способ их получения |
-
1999
- 1999-01-07 EA EA200000742A patent/EA002881B1/ru not_active IP Right Cessation
- 1999-01-07 IL IL13700499A patent/IL137004A0/xx unknown
- 1999-01-07 PT PT99900136T patent/PT1051978E/pt unknown
- 1999-01-07 JP JP2000527279A patent/JP3413406B2/ja not_active Expired - Lifetime
- 1999-01-07 BR BRPI9907084A patent/BRPI9907084B8/pt not_active IP Right Cessation
- 1999-01-07 TR TR2000/01903T patent/TR200001903T2/xx unknown
- 1999-01-07 CZ CZ20002542A patent/CZ302082B6/cs not_active IP Right Cessation
- 1999-01-07 CN CNB998027855A patent/CN1151845C/zh not_active Expired - Lifetime
- 1999-01-07 ID IDW20001303A patent/ID25469A/id unknown
- 1999-01-07 NZ NZ505871A patent/NZ505871A/xx not_active IP Right Cessation
- 1999-01-07 EP EP99900136A patent/EP1051978B1/en not_active Expired - Lifetime
- 1999-01-07 PL PL99341589A patent/PL194097B1/pl unknown
- 1999-01-07 AU AU17845/99A patent/AU736555B2/en not_active Ceased
- 1999-01-07 HU HU0101272A patent/HU230295B1/hu unknown
- 1999-01-07 CA CA002316841A patent/CA2316841C/en not_active Expired - Lifetime
- 1999-01-07 ES ES99900136T patent/ES2393972T3/es not_active Expired - Lifetime
- 1999-01-07 WO PCT/JP1999/000020 patent/WO1999034832A1/ja not_active Ceased
- 1999-01-07 SK SK1026-2000A patent/SK286631B6/sk not_active IP Right Cessation
- 1999-01-07 US US09/582,937 patent/US6342493B1/en not_active Expired - Lifetime
- 1999-01-07 KR KR10-2000-7007546A patent/KR100435315B1/ko not_active Expired - Lifetime
- 1999-06-28 TW TW088110903A patent/TW587946B/zh not_active IP Right Cessation
- 1999-07-01 UA UA2000084638A patent/UA70311C2/uk unknown
-
2000
- 2000-06-26 IL IL137004A patent/IL137004A/en not_active IP Right Cessation
-
2001
- 2001-11-26 US US09/991,694 patent/US6486149B2/en not_active Expired - Lifetime
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BRPI9907084B8 (pt) | processo para a preparação de uma composição compreendendo cefalosporina amorfa cristalograficamente estável | |
| IE39517L (en) | Double salts of s-adenosyl-l-methionine | |
| HUT67653A (en) | Nor-bile-acid derivatives, process for producing them and pharmaceutical compositions containing them | |
| CA2334773A1 (en) | Benzothiepine-1,1-dioxide derivatives, method for producing them, medicaments containing these compounds and their use | |
| BR0007781A (pt) | Conjugado fisiologicamente ativo, composição, e, processo para a produção de um conjugado de peg-gcsf | |
| IL96550A0 (en) | Amino acid derivatives,their manufacture and pharmaceutical compositions containing them | |
| BG103945A (en) | Derivatives of 4"-substituted-9-deoxo-9a-aza-9a-homoerythromycin a | |
| PT81264B (pt) | Processo para a preparacao de solucoes injectaveis estabilizadas de piroxicamo | |
| AP9801378A0 (en) | 9-amino-3- keto erythromycin derivatives. | |
| GB8727482D0 (en) | Derivatives of cyclohexane | |
| CA2286511A1 (en) | Novel macrolide derivatives | |
| EP0233946A4 (en) | CHROMOGLYCIC ACID DERIVATIVES, PREPARATION METHOD AND MEDICINAL COMPOSITION. | |
| EP0537492A3 (en) | Stable salts of 5,10-methylenetetrahydrofolic acid | |
| AP9801377A0 (en) | Tricyclic erythromycin derivatives. | |
| DE3369983D1 (en) | Isoquinoline derivatives, process for their preparation, pharmaceutical compositions containing them and their use | |
| IE40957B1 (en) | A 4-0- ,d glucopyransyl-2-deoxystreptamine, a process for its preparing, and compositions incorporating it | |
| SE8302979D0 (sv) | Piperazine derivatives, their production and pharmaceutical compositions containing them | |
| ATE151770T1 (de) | Cephalosporinverbindungen und deren herstellung | |
| DK320485A (da) | Ether-oxid-derivater af cyclopropylphenoler, deres fremstilling oganvendelse | |
| HRP20020238A2 (en) | 4-benzylaminoquinoline conjugates with bile acid and their heteroanalogues, methods for producing the same, medicaments containing these compounds and their use | |
| IL66473A0 (en) | Aminoglycoside derivatives,their production and pharmaceutical compositions containing them | |
| IE56229B1 (en) | 2-piperazinyl-or-homopiperazinyl-quinazoline derivatives their production and pharmaceutical compositions containing them | |
| CA2119661A1 (fr) | Nouveaux composes de n-benzylpiperazine, leur procede de preparation et les compositions pharmaceutiques les renfermant | |
| KR850006543A (ko) | 세폰니시드 모노나트륨 염 | |
| JPS565412A (en) | Pharmaceutical composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07A | Application suspended after technical examination (opinion) [chapter 7.1 patent gazette] | ||
| B15K | Others concerning applications: alteration of classification |
Free format text: ALTERADA DA INT.CL: A61K 9/14, A61K 31/545, A61K 31/546, C07D 501/00, C07D 501/24 Ipc: A61K 47/38 (2009.01), C07D 501/24 (2009.01) |
|
| B09B | Patent application refused [chapter 9.2 patent gazette] |
Free format text: INDEFERIDO O PEDIDO COM BASE NOS ARTIGOS 8O,13 E 25 DA LPI. |
|
| B12B | Appeal against refusal [chapter 12.2 patent gazette] | ||
| B07E | Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette] | ||
| B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
| B09Y | Publication of grant cancelled [chapter 9.1.2 patent gazette] |
Free format text: REFERENCIA RPI 2147- CODIGO 9.1 |
|
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: MEIJI SEIKA KAISHA, LTD (JP) Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 20120104493/RJ, DE 08/11/2012, E NECESSARIO APRESENTAR O DOCUMENTO DE ALTERACAO DE NOME NOTARIZADO E COM A DEVIDA LEGALIZACAO CONSULAR. |
|
| B25F | Entry of change of name and/or headquarter and transfer of application, patent and certif. of addition of invention: change of name on requirement |
Owner name: MEIJI SEIKA KAISHA, LTD (JP) Free format text: A FIM DE ATENDER A ALTERACAO DE NOME REQUERIDA ATRAVES DA PETICAO NO 20130077706/RJ DE 23/09/2013, E NECESSARIO APRESENTAR O DOCUMENTO DE ALTERACAO NOTARIZADO E COM A DEVIDA LEGALIZACAO CONSULAR. |
|
| B25E | Requested change of name of applicant rejected |
Owner name: MEIJI SEIKA KAISHA, LTD (JP) Free format text: INDEFERIDO(S) O(S) PEDIDO(S) DE ALTERACAO(OES) DE NOME CONTIDO(S) NA PETICAO NO 20120104493, DE 08/11/2012, POR AUSENCIA DE CUMPRIMENTO DA EXIGENCIA PUBLICADA NA RPI NO 2291, DE 02/12/2014. |
|
| B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] | ||
| B25D | Requested change of name of applicant approved | ||
| B16C | Correction of notification of the grant [chapter 16.3 patent gazette] |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 07/01/1999 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF |
|
| B21A | Patent or certificate of addition expired [chapter 21.1 patent gazette] |
Free format text: PATENTE EXTINTA EM 07/01/2019 |